• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Intraoperative Neurophysiological Monitoring Market Size

    ID: MRFR/MED/0258-CR
    114 Pages
    Rahul Gotadki
    August 2019

    Intraoperative Neurophysiological Monitoring Market Research Report Information By Surgical Procedure (Orthopedic, Urology, Spinal, Neurovascular, and Otolaryngology Surgery), By Type (Electroencephalography, Evoked Potentials, and Electromyography), By Methods (Outsourced, In-House, and Tele-Health), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast T...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Intraoperative Neurophysiological Monitoring Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Intraoperative Neurophysiological Monitoring Size

    Intraoperative Neurophysiological Monitoring Market Growth Projections and Opportunities

    The electroencephalography (EEG) segment emerged as the largest in the intraoperative neurophysiological monitoring market, recording a revenue of $670.1 million in 2015. It is projected to escalate to $1816.1 million by 2027, exhibiting a growth rate of 8.6% from 2016 to 2027. Simultaneously, electromyography (EMG) is identified as the fastest-growing segment, anticipated to experience a remarkable 9.3% compound annual growth rate (CAGR) during the forecast period.

    Within the type category, EEG dominated the market, securing the largest market share in 2015, generating $670.1 million in revenue. This segment is on a trajectory to reach $1816.1 million by 2027, reflecting an 8.6% CAGR. Conversely, EMG is emerging as the fastest-growing segment, poised for an impressive 9.3% CAGR over the forecasted period.

    Examining the intraoperative neurophysiological monitoring market by procedure, the spinal segment took the lead, accruing $748.4 million in revenue in 2015. Projections indicate an upswing to $2052.6 million by 2027, growing at a rate of 8.7% from 2016 to 2027. In tandem, orthopedic procedures are identified as the fastest-growing segment, expected to expand at a rate of 9.3% from 2016 to 2027.

    In terms of procedures, spinal interventions held the largest market share, amassing $748.4 million in revenue in 2015. Forecasts suggest a substantial increase to $2052.6 million by 2027, reflecting an 8.7% CAGR. Simultaneously, orthopedic procedures are identified as the fastest-growing segment, poised for a noteworthy 9.3% CAGR during the forecasted period.

    Segmenting the intraoperative neurophysiological monitoring market by method, the invasive segment exhibited dominance with a revenue of $687.5 million in 2015. Projections signal an upward trajectory, reaching $1862.7 million by 2027, growing at a rate of 8.6% from 2016 to 2027. In parallel, the non-invasive segment stands out as the fastest-growing, poised to expand at a rate of 9.3% from 2016 to 2027.

    Examining the market by method, the invasive approach garnered the largest market share, amassing $687.5 million in revenue in 2015. Forecasts predict a robust increase to $1862.7 million by 2027, reflecting an 8.6% CAGR. Simultaneously, the non-invasive method emerges as the fastest-growing segment, poised for a noteworthy 9.3% CAGR during the forecasted period.

    By source, the in-house segment led the intraoperative neurophysiological monitoring market, generating $670.4 million in revenue in 2015. Projections indicate an upward trajectory, reaching $1828.3 million by 2027, with a growth rate of 8.7% from 2016 to 2027. Meanwhile, the outsourced segment is identified as the fastest-growing, expected to expand at a rate of 9.2% from 2016 to 2027.

    Analyzing the market by source, the in-house segment exhibited dominance, securing the largest market share with $670.4 million in revenue in 2015. Forecasts suggest substantial growth to $1828.3 million by 2027, reflecting an 8.7% CAGR. Concurrently, the outsourced segment emerges as the fastest-growing, anticipated to expand at an impressive 9.2% CAGR during the forecasted period.

    Intraoperative Neurophysiological Monitoring Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Intraoperative Neurophysiological Monitoring Market was valued at 2.13 USD Billion in 2024 and is projected to grow to 5.46 USD Billion by 2035, with a CAGR of 8.92% from 2025 to 2035. The market is driven by the increasing demand for neuromonitoring technologies among surgeons and hospitals, alongside advancements in IONM technology. Key developments include FDA approvals for various monitoring systems and strategic acquisitions by major players to enhance their product portfolios.

    Key Market Trends & Highlights

    The market is witnessing significant growth due to technological advancements and increasing prevalence of neurological disorders.

    • Market Size in 2024: USD 2.13 Billion; Expected to reach USD 5.46 Billion by 2035.
    • CAGR from 2025 to 2035: 8.92%; driven by advancements in IONM technology.
    • North America accounted for USD 0.8244 Billion in 2022; expected to grow significantly due to favorable reimbursement policies.
    • Electromyography segment dominated the market in 2022; projected to be the fastest-growing segment during 2022-2030.

    Market Size & Forecast

    2024 Market Size USD 2.13 Billion
    2035 Market Size USD 5.46 Billion
    CAGR (2025-2035) 8.92%
    Largest Regional Market Share in 2022 North America.

    Major Players

    Key players include Cadwell Laboratories, IntraNerve, NeuroMonitoring Technologies, ProPep Surgical, Sentient Medical Systems, Accurate Monitoring LLC, Natus Medical Incorporated, NuVasive, Medsurant Holdings, Inomed Medizintechnik GmbH.

    Market Trends

    Growing Prevalence of spine degeneration to boost the market growth

    It has been a key part of manufacturers' product differentiation strategies to monitor the nervous system's health during spinal surgery. The need for neuromonitoring from surgeons and hospitals has grown over time due to advancements in IONM technology and techniques. This results from the manufacturer's proprietary software and ease of use. The ability of surgeons to make critical decisions in real-time thanks to intraoperative neuromonitoring devices makes operations safer, quicker, and more repeatable, which improves patient outcomes and is expected to drive growth.

    Additionally, developing cutting-edge tools like surgical robots, microscopes,ophthalmic surgical tools, and neurosurgery tools has reduced direct human interference in surgical procedures, which is also anticipated to support market growth in the near future. For example, the U.S. Food and Drug Administration granted 510(k) clearance to Medtronic plc in October 2020. S. To help lower the risk of nerve damage during head and neck surgeries, the FDA has approved the NIM Vital nerve monitoring system, which enables doctors to detect, monitor, and confirm nerve function.

    The NIM Vital system uses patented technology to deliver precise intraoperative nerve status data that affect surgical strategy and increase operative effectiveness. In the near future, growth is anticipated to be fueled by these factors.

    Additionally, developing cutting-edge tools like surgical robots, microscopes, ophthalmic surgical tools, and neurosurgery tools has reduced direct human interference in surgical procedures, which is also anticipated to support market growth in the near future. For instance, the U.S. FDA granted 510(k) clearance to Medtronic Plc in October 2020 in the U.S. To help lower the risk of nerve damage during head and neck surgeries, the FDA approved the NIM Vital nerve monitoring system, which enables doctors to detect, monitor, and confirm nerve function.

    The NIM Vital system uses patented technology to deliver accurate intraoperative nerve status information that affects surgical strategy and increases operative efficiency. In the near future, growth is anticipated to be fueled by these factors, which has enhanced the Intraoperative Neurophysiological Monitoring market CAGR globally in recent years.

    The increasing complexity of surgical procedures necessitates the integration of advanced neurophysiological monitoring techniques to enhance patient safety and surgical outcomes.

    U.S. National Institutes of Health

    Intraoperative Neurophysiological Monitoring Market Market Drivers

    Regulatory Support and Guidelines

    Regulatory bodies are increasingly recognizing the importance of intraoperative neurophysiological monitoring, leading to the establishment of supportive guidelines that promote its use in surgical settings. This regulatory support is crucial for the Global Intraoperative Neurophysiological Monitoring Market Industry, as it encourages healthcare facilities to adopt these monitoring techniques. Enhanced regulations ensure that monitoring practices meet safety and efficacy standards, thereby boosting confidence among healthcare providers. As a result, the market is poised for growth, with the potential for increased investments in monitoring technologies and training programs for surgical teams.

    Rising Demand for Surgical Procedures

    The Global Intraoperative Neurophysiological Monitoring Market Industry experiences a notable surge in demand due to the increasing number of surgical procedures performed worldwide. As healthcare systems evolve, the integration of advanced monitoring techniques becomes essential for ensuring patient safety and optimal surgical outcomes. For instance, the market is projected to reach 2.13 USD Billion in 2024, reflecting a growing recognition of the importance of intraoperative neurophysiological monitoring in complex surgeries. This trend is likely to continue, driven by advancements in surgical technologies and an increasing focus on minimizing neurological complications during operations.

    Expansion of Healthcare Infrastructure

    The expansion of healthcare infrastructure, particularly in emerging economies, is a significant driver for the Global Intraoperative Neurophysiological Monitoring Market Industry. As hospitals and surgical centers upgrade their facilities and invest in advanced technologies, the demand for intraoperative monitoring solutions is likely to rise. This trend is particularly evident in regions where access to quality surgical care is improving, leading to a greater emphasis on patient safety and outcomes. The ongoing development of healthcare infrastructure suggests a robust future for the market, as more facilities integrate neurophysiological monitoring into their surgical protocols.

    Technological Advancements in Monitoring Equipment

    Technological innovations play a pivotal role in shaping the Global Intraoperative Neurophysiological Monitoring Market Industry. The development of sophisticated monitoring devices, such as portable and real-time neurophysiological monitoring systems, enhances the accuracy and reliability of intraoperative assessments. These advancements not only improve surgical outcomes but also facilitate quicker recovery times for patients. As a result, the market is expected to grow significantly, with projections indicating a rise to 5.47 USD Billion by 2035. The continuous evolution of technology in this field suggests a promising future for both healthcare providers and patients.

    Increasing Awareness of Neurophysiological Monitoring Benefits

    There is a growing awareness among healthcare professionals and patients regarding the benefits of intraoperative neurophysiological monitoring, which is significantly influencing the Global Intraoperative Neurophysiological Monitoring Market Industry. This awareness is driven by educational initiatives and clinical evidence demonstrating the effectiveness of monitoring techniques in reducing postoperative complications. As more surgeons adopt these practices, the market is likely to expand, supported by a projected compound annual growth rate of 8.95% from 2025 to 2035. This trend indicates a shift towards more proactive approaches in surgical care, emphasizing the importance of real-time monitoring.

    Market Segment Insights

    Intraoperative Neurophysiological Monitoring Surgical Procedure Insights

    Based on Surgical Procedure, the Intraoperative Neurophysiological Monitoring Market segmentation includes Orthopedic, Urology, Spinal, Neurovascular, and Otolaryngology Surgery. The Spinal segment held the majority share in 2022 contribution concerning the Intraoperative Neurophysiological Monitoring Market revenue. It can also evaluate the spinal cord and nerve roots after surgery to ensure proper cervical spine positioning. Its use in cervical spine surgery is wider than monitoring sensory tracts during the procedure. But SSEP changes during surgery are not always linked to postoperative neurological deficits because of its allegedly low specificity34, according to 33–35 studies.

    As a result, many researchers advise against using it as the sole monitoring modality in difficult cervical procedures.

    Intraoperative Neurophysiological Monitoring Type Insights

    The Intraoperative Neurophysiological Monitoring Market segmentation, based on type, includes Electroencephalography, Evoked Potentials, and Electromyography. The Electromyography segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The motor neurons that control muscles and the muscles are evaluated using a diagnostic procedure called electromyography (EMG). According to EMG results, there may be issues with nerve-to-muscle signal transmission, muscle dysfunction, or both positively impact the market growth.

    Intraoperative Neurophysiological Monitoring Methods Insights

    The Intraoperative Neurophysiological Monitoring Market data has been bifurcated by surgery into Outsourced, In-House, and Tele-Health. The Outsourced segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Hospitals and healthcare facilities outsource their IONM needs due to cost-effectiveness and the availability of specialized service providers. IONM technology is constantly evolving and changing. Hospitals are relieved of the cost of purchasing and maintaining this equipment thanks to outsourcing. Additionally, training neurophysiologists is costly and time-consuming.

    Figure 1: Intraoperative Neurophysiological Monitoring Market, by Methods, 2022 & 2030 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about Intraoperative Neurophysiological Monitoring Market Research Report - Global Forecast to 2034

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Intraoperative Neurophysiological Monitoring market accounted for USD 0.8244 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. According to the U.S. National Institute of Health, this dominance is largely due to the favorable reimbursement environment and rising neurological disorder cases. Around 795,000 people have a stroke annually, which results in 137,000 fatalities. Additionally, the Migraine Research Foundation estimates that in 2020, about 35 million U.S. people will experience migraine headaches.

    Additionally, it is anticipated that 18% of men and 43% of women will suffer from migraines nationwide.

    Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET SHARE BY REGION 2022 (%)INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe’s Intraoperative Neurophysiological Monitoring market accounts for the second-largest market share. Approximately 35 million people in the United States experience migraine headaches, according to statistics from the Migraine Research Foundation that were updated in 2021. Additionally, it is anticipated that 18% of men and 43% of women will suffer from migraines nationwide. Therefore, it is likely that the rise in neurological disorders like TBI, migraine, and stroke will propel market expansion in this nation.

    Further, the Germany Intraoperative Neurophysiological Monitoring market held the largest market share, and the UK Intraoperative Neurophysiological Monitoring market was the fastest-growing market in the European region.

    The Asia-Pacific Intraoperative Neurophysiological Monitoring Market is expected to grow at the fastest CAGR from 2022 to 2030. Over the forecast period, emerging economies like China, Japan, South Korea, and India will experience significant growth. In China and Japan, numerous local players may foster market expansion. Additionally, it is anticipated that the local market will be driven in the upcoming years by the growing geriatric population and the incidence of traumatic brain injuries. For example, the national 2020 census estimates that about 264 million (18.7%) Chinese are 60 or older.

    Moreover, China’s Intraoperative Neurophysiological Monitoring market held the largest market share, and India’s Intraoperative Neurophysiological Monitoring market was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are spending much money on R&D to increase their product lines, which will help the Intraoperative Neurophysiological Monitoring market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Intraoperative Neurophysiological Monitoring industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    One of the primary business strategies manufacturers adopt in the Global Intraoperative Neurophysiological Monitoring industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. In recent years, the Intraoperative Neurophysiological Monitoring industry has provided medicine with some of the most significant benefits.

    In the Intraoperative Neurophysiological Monitoring market, major players such as Cadwell Laboratories (US), IntraNerve (US), NeuroMonitoring Technologies (US), ProPep Surgical (US),  Sentient Medical Systems (US), Accurate Monitoring LLC (US), Natus Medical Incorporated (US), NuVasive (US), Medsurant Holdings (US), Inomed Medizintechnik GmbH (Germany) and others are working on expanding the market demand by investing in research and development activities.

    Cadwell Laboratories (US): During his residency at the University of Washington School of Medicine, John Cadwell, MD, BSEE, created the first microprocessor EMG in his Seattle home's basement. He co-founds Cadwell Laboratories with his brother, Carl Cadwell, DDS. The Cadwell 7000 EMG is their initial offering. Putting Cadwell on the map is the 5200A. This machine, which is compact, strong, reliable, and simple to use, has become the most popular EMG device ever produced. The business has outgrown its previous location and relocated to 909 N. Street Kellogg in 1986.

    The next generation of ApneaTrak HSAT is introduced with completely disposable patient kits to assist sleep laboratories in providing secure home testing options. Serving new markets and enhancing its offerings, Cadwell keeps growing. The business stays true to its purpose: assisting you in aiding others.

    Also, IntraNerve (US) is a planned rollout that identifies development-related issues that have been extremely beneficial. I saw [INN] gently guiding individuals in my organization toward contracting and credentialing. The services provided by [INN] will enhance patient care, and we directly benefit from them. We are a full-service tertiary care facility, so if we didn't have the option of working with [INN], we could create our expertise.

    Key Companies in the Intraoperative Neurophysiological Monitoring Market market include

    Industry Developments

    INVASIVE INC. announced the official opening of its Singapore Experience Center for the Asia-Pacific region, supporting its growth strategy to expand its business internationally.

    March 2021

    The V4 4-channel and 8-channel nerve monitoring systems from Neurosign have received approval from the US Food and Drug Administration, and they are currently being used on patients in the US for nerve identification and preservation.

    Future Outlook

    Intraoperative Neurophysiological Monitoring Market Future Outlook

    The Intraoperative Neurophysiological Monitoring Market is projected to grow at 8.92% CAGR from 2025 to 2035, driven by technological advancements, increasing surgical procedures, and heightened patient safety awareness.

    New opportunities lie in:

    • Develop AI-driven monitoring systems to enhance real-time data analysis and decision-making.
    • Expand service offerings to include remote monitoring solutions for post-operative care.
    • Invest in training programs for surgical teams to optimize the use of neurophysiological monitoring technologies.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a critical component of surgical safety.

    Market Segmentation

    Intraoperative Neurophysiological Monitoring Type Outlook

    • Electroencephalography
    • Evoked Potentials
    • Electromyography

    Intraoperative Neurophysiological Monitoring Methods Outlook

    • Outsourced
    • In-House
    • Tele-Health

    Intraoperative Neurophysiological Monitoring Regional Outlook

    North America
    • US
    • Canada

    Intraoperative Neurophysiological Monitoring Surgical Procedure Outlook

    • Orthopedic
    • Urology
    • Spinal
    • Neurovascular
    • Otolaryngology Surgery

    Report Scope

    Attribute/Metric Details
    Market Size 2024    2.13 (USD Billion)
    Market Size 2025    2.33 (USD Billion)
    Market Size 2035 5.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.92% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Surgical Procedure, Type, Methods and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Cadwell Laboratories (US), IntraNerve (US),  NeuroMonitoring Technologies (US), ProPep Surgical (US),  Sentient Medical Systems (US), Accurate Monitoring LLC (US), Natus Medical Incorporated (US), NuVasive (US), Medsurant Holdings (US), Inomed Medizintechnik GmbH (Germany)
    Key Market Opportunities Development of cutting-edge tools like surgical robots
    Key Market Dynamics Rising world population and average life expectancy.

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is the projected growth of the Intraoperative Neurophysiological Monitoring market?

    The Intraoperative Neurophysiological Monitoring market is the expected increase in total market value of 5.46 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Intraoperative Neurophysiological Monitoring market?

    Intraoperative Neurophysiological Monitoring market size was valued at approximately 2.13 billion USD in 2024. This figure will reach 5.46 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Intraoperative Neurophysiological Monitoring market?

    Intraoperative Neurophysiological Monitoring market is expected to grow at a CAGR of 8.92% between 2025 and 2035.

    How much will the Intraoperative Neurophysiological Monitoring market be worth by 2035?

    Intraoperative Neurophysiological Monitoring market is expected to be worth of 5.46 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Intraoperative Neurophysiological Monitoring market perform over the next 10 years?

    Over the next 10 years the Intraoperative Neurophysiological Monitoring market is expected to shift from usd billion 2.13 to 5.46 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region held the largest market share in the Intraoperative Neurophysiological Monitoring market?

    North America had the largest share of the Global market

    1. INTRODUCTION\r\n \r\n1.1 DEFINITION 13\r\n \r\n1.2
      1. SCOPE OF STUDY 13\r\n \r\n1.2.1 RESEARCH OBJECTIVE 13\r\n \r\n1.2.2
      2. ASSUMPTIONS & LIMITATIONS 14\r\n \r\n1.2.2.1 ASSUMPTIONS
      3. 14\r\n \r\n1.2.2.2 LIMITATIONS 14\r\n \r\n1.3
      4. MARKET STRUCTURE: 14\r\n \r\n2 RESEARCH METHODOLOGY\r\n \r\n2.1
      5. RESEARCH PROCESS: 15\r\n \r\n2.2 PRIMARY RESEARCH 16\r\n \r\n2.3
      6. SECONDARY RESEARCH 16\r\n \r\n3 MARKET DYNAMICS\r\n \r\n3.1
      7. DRIVERS 17\r\n \r\n3.1.1 INCREASE IN SURGERY VOLUME 17\r\n \r\n3.1.2
      8. IONM TECHNIQUES REDUCE HEALTH CARE COSTS 17\r\n \r\n3.1.3
      9. INCREASE IN AWARENESS OF IONM 18\r\n \r\n3.1.4 SIGNIFICANT
      10. REDUCTION IN MORBIDITY AND MORTALITY RATES 18\r\n \r\n3.2
      11. RESTRAINTS 18\r\n \r\n3.2.1 SHORTAGE OF THE SKILLED PERSONNEL
      12. 18\r\n \r\n3.3 OPPORTUNITIES 19\r\n \r\n3.4
      13. MACROECONOMIC INDICATORS 19\r\n \r\n4 INTRAOPERATIVE
    2. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE\r\n \r\n4.1
      1. ELECTROENCEPHALOGRAPHY 22\r\n \r\n4.2 ELECTROMYOGRAPHY
      2. 22\r\n \r\n4.3 EVOKED POTENTIALS 23\r\n \r\n5
    3. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE\r\n \r\n5.1
      1. SPINAL 27\r\n \r\n5.2 NEUROVASCULAR 27\r\n \r\n5.3
      2. ORTHOPEDIC 29\r\n \r\n5.4 OTOLARYNGOLOGY SURGERY 30\r\n \r\n5.5
      3. UROLOGY 31\r\n \r\n6 INTRAOPERATIVE NEUROPHYSIOLOGICAL
    4. MONITORING MARKET, BY METHODS\r\n \r\n6.1 INVASIVE 34\r\n \r\n6.2
      1. NON INVASIVE 34\r\n \r\n6.3 MINIMALLY INVASIVE 35\r\n \r\n7
    5. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE\r\n \r\n7.1
      1. IN-HOUSE 39\r\n \r\n7.2 OUTSOURCED 39\r\n \r\n7.3
      2. TELE-HEALTH 41\r\n \r\n8 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
    6. MONITORING MARKET, BY REGION\r\n \r\n8.1 NORTH AMERICA
      1. 43\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING
    7. MARKET, BY TYPE\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    8. MONITORING MARKET, BY PROCEDURE\r\n \r\nINTRAOPERATIVE
    9. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS\r\n \r\nINTRAOPERATIVE
    10. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE\r\n \r\n8.2
      1. EUROPE 53\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING
    11. MARKET, BY TYPE\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    12. MONITORING MARKET, BY PROCEDURE\r\n \r\nINTRAOPERATIVE
    13. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS\r\n \r\nINTRAOPERATIVE
    14. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE\r\n \r\n8.3
      1. ASIA-PACIFIC 71\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    15. MONITORING MARKET, BY TYPE\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    16. MONITORING MARKET, BY PROCEDURE\r\n \r\nINTRAOPERATIVE
    17. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS\r\n \r\nINTRAOPERATIVE
    18. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE\r\n \r\n8.4
      1. MIDDLE EAST & AFRICA 84\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    19. MONITORING MARKET, BY TYPE\r\n \r\nINTRAOPERATIVE NEUROPHYSIOLOGICAL
    20. MONITORING MARKET, BY PROCEDURE\r\n \r\nINTRAOPERATIVE
    21. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS\r\n \r\nINTRAOPERATIVE
    22. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE\r\n \r\n9
      1. COMPANY PROFILE\r\n \r\n9.1 ACCURATE MONITORING LLC 93\r\n \r\n9.1.1
      2. OVERVIEW 93\r\n \r\n9.1.2 PRODUCT OVERVIEW 93\r\n \r\n9.1.3
      3. FINANCIALS 93\r\n \r\n9.1.4 KEY DEVELOPMENTS 93\r\n \r\n9.2
      4. ARGOS NEUROMONITORING LP 94\r\n \r\n9.2.1 OVERVIEW 94\r\n \r\n9.2.2
      5. PRODUCT OVERVIEW 94\r\n \r\n9.2.3 FINANCIALS 94\r\n \r\n9.2.4
      6. KEY DEVELOPMENTS 94\r\n \r\n9.3 CADWELL LABORATORIES
      7. INC. 95\r\n \r\n9.3.1 OVERVIEW 95\r\n \r\n9.3.2
      8. PRODUCT OVERVIEW 95\r\n \r\n9.3.3 FINANCIALS 95\r\n \r\n9.3.4
      9. KEY DEVELOPMENTS 95\r\n \r\n9.4 COMPUTATIONAL DIAGNOSTICS
      10. INC. 96\r\n \r\n9.4.1 OVERVIEW 96\r\n \r\n9.4.2
      11. PRODUCT OVERVIEW 96\r\n \r\n9.4.3 FINANCIALS 96\r\n \r\n9.4.4
      12. KEY DEVELOPMENTS 96\r\n \r\n9.5 EMOTIV 97\r\n \r\n9.5.1
      13. OVERVIEW 97\r\n \r\n9.5.2 PRODUCT OVERVIEW 97\r\n \r\n9.5.3
      14. FINANCIALS 97\r\n \r\n9.5.4 KEY DEVELOPMENTS 98\r\n \r\n9.6
      15. INOMED MEDIZINTECHNIK GMBH 99\r\n \r\n9.6.1 OVERVIEW
      16. 99\r\n \r\n9.6.3 FINANCIALS 99\r\n \r\n9.6.4
      17. KEY DEVELOPMENTS 99\r\n \r\n9.7 INTRANERVE 100\r\n \r\n9.7.1
      18. OVERVIEW 100\r\n \r\n9.7.3 FINANCIALS 100\r\n \r\n9.7.4
      19. KEY DEVELOPMENTS 100\r\n \r\n9.8 MEDTRONIC 101\r\n \r\n9.8.1
      20. OVERVIEW 101\r\n \r\n9.8.2 PRODUCT OVERVIEW 101\r\n \r\n9.8.4
      21. KEY DEVELOPMENTS 102\r\n \r\n9.9 MEDSURANT HOLDINGS (ADVANCED
      22. MEDICAL RESOURCES) 103\r\n \r\n9.9.1 OVERVIEW 103\r\n \r\n9.9.2
      23. PRODUCT OVERVIEW 103\r\n \r\n9.9.3 FINANCIALS 103\r\n \r\n9.9.4
      24. KEY DEVELOPMENTS 103\r\n \r\n9.10 NATUS MEDICAL INCORPORATED
      25. 104\r\n \r\n9.10.1 OVERVIEW 104\r\n \r\n9.10.2
      26. PRODUCT OVERVIEW 104\r\n \r\n9.10.3 FINANCIALS 104\r\n \r\n9.10.4
      27. KEY DEVELOPMENTS 104\r\n \r\n9.11 NEURO ALERT 105\r\n \r\n9.11.1
      28. OVERVIEW 105\r\n \r\n9.11.3 FINANCIALS 105\r\n \r\n9.11.4
      29. KEY DEVELOPMENTS 105\r\n \r\n9.12 NEUROMONITORING TECHNOLOGIES,
      30. INC. 106\r\n \r\n9.12.1 OVERVIEW 106\r\n \r\n9.12.2
      31. PRODUCT OVERVIEW 106\r\n \r\n9.12.3 FINANCIALS 106\r\n \r\n9.12.4
      32. KEY DEVELOPMENTS 106\r\n \r\n9.13 NEUROSENTINEL LLC 107\r\n \r\n9.13.1
      33. OVERVIEW 107\r\n \r\n9.13.2 PRODUCT OVERVIEW 107\r\n \r\n9.13.3
      34. FINANCIALS 107\r\n \r\n9.13.4 KEY DEVELOPMENTS 107\r\n \r\n9.14
      35. NUVASIVE 108\r\n \r\n9.14.1 OVERVIEW 108\r\n \r\n9.14.2
      36. PRODUCT OVERVIEW 108\r\n \r\n9.14.3 FINANCIALS 108\r\n \r\n9.14.4
      37. KEY DEVELOPMENTS 109\r\n \r\n9.15 PROCIRCA 110\r\n \r\n9.15.1
      38. OVERVIEW 110\r\n \r\n9.15.2 PRODUCT OVERVIEW 110\r\n \r\n9.15.3
      39. FINANCIALS 110\r\n \r\n9.15.4 KEY DEVELOPMENTS 110\r\n \r\n9.16
      40. PROPEP SURGICAL 111\r\n \r\n9.16.1 OVERVIEW 111\r\n \r\n9.16.2
      41. PRODUCT OVERVIEW 111\r\n \r\n9.16.3 FINANCIALS 111\r\n \r\n9.16.4
      42. KEY DEVELOPMENTS 111\r\n \r\n9.17 SPECIALTYCARE 112\r\n \r\n9.17.1
      43. OVERVIEW 112\r\n \r\n9.17.2 PRODUCT OVERVIEW 112\r\n \r\n9.17.3
      44. FINANCIALS 112\r\n \r\n9.17.4 KEY DEVELOPMENTS 112\r\n \r\n9.18
      45. SENTIENT MEDICAL SYSTEMS 113\r\n \r\n9.18.1 OVERVIEW
      46. 113\r\n \r\n9.18.2 PRODUCT OVERVIEW 113\r\n \r\n9.18.3
      47. FINANCIALS 113\r\n \r\n9.18.4 KEY DEVELOPMENTS 113\r\n \r\n10
      48. LIST OF TABLES\r\n \r\nTABLE 1 GLOBAL INTRAOPERATIVE
    23. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 21\r\n \r\nTABLE
    24. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROENCEPHALOGRAPHY,
      1. BY REGION, 2023–2030 (USD MILLION) 22\r\n \r\nTABLE
    25. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: ELECTROMYOGRAPHY,
      1. BY REGION, 2023–2030 (USD MILLION) 23\r\n \r\nTABLE
    26. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET: EVOKED POTENTIALS,
      1. BY REGION, 2023–2030 (USD MILLION) 24\r\n \r\nTABLE
    27. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 26\r\n \r\nTABLE 6 GLOBAL INTRAOPERATIVE
    28. NEUROPHYSIOLOGICAL MONITORING MARKET: SPINAL, BY REGION, 2023–2030 (USD MILLION)
      1. 27\r\n \r\nTABLE 7 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
    29. MONITORING MARKET: NEUROVASCULAR, BY REGION, 2023–2030 (USD MILLION) 28\r\n \r\nTABLE
    30. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 33\r\n \r\nTABLE 12 GLOBAL INTRAOPERATIVE
      2. NEUROPHYSIOLOGICAL MONITORING MARKET, INVASIVE, 2023–2030 (USD MILLION) 34\r\n \r\nTABLE
    31. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, NON INVASIVE, 2023–2030
      1. (USD MILLION) 35\r\n \r\nTABLE 14 GLOBAL INTRAOPERATIVE
      2. NEUROPHYSIOLOGICAL MONITORING MARKET, MINIMALLY INVASIVE, 2023–2030 (USD MILLION)
      3. 35\r\n \r\nTABLE 15 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
    32. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 38\r\n \r\nTABLE
    33. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, IN-HOUSE, 2023–2030
      1. (USD MILLION) 39\r\n \r\nTABLE 17 GLOBAL INTRAOPERATIVE
      2. NEUROPHYSIOLOGICAL MONITORING MARKET, OUTSOURCED, 2023–2030 (USD MILLION)
      3. 40\r\n \r\nTABLE 18 GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL
      4. MONITORING MARKET, TELE-HEALTH, 2023–2030 (USD MILLION) 41\r\n \r\nTABLE
    34. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2023–2030
      1. (USD MILLION) 42\r\n \r\nTABLE 20 NORTH AMERICA INTRAOPERATIVE
    35. NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 43\r\n \r\nTABLE
    36. NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY,
    37. AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 44\r\n \r\nTABLE
    38. NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 45\r\n \r\nTABLE 24 NORTH AMERICA INTRAOPERATIVE
    39. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 46\r\n \r\nTABLE 25 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    40. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 47\r\n \r\nTABLE
    41. NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE,
    42. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      1. MILLION) 48\r\n \r\nTABLE 28 US INTRAOPERATIVE NEUROPHYSIOLOGICAL
    43. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 49\r\n \r\nTABLE
    44. US INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 49\r\n \r\nTABLE 30 US INTRAOPERATIVE NEUROPHYSIOLOGICAL
    45. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 50\r\n \r\nTABLE
    46. CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 50\r\n \r\nTABLE 32 CANADA INTRAOPERATIVE
    47. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 51\r\n \r\nTABLE 33 CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    48. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 51\r\n \r\nTABLE
    49. CANADA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 52\r\n \r\nTABLE 35 EUROPE INTRAOPERATIVE
    50. NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
      1. 54\r\n \r\nTABLE 36 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
    51. MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 55\r\n \r\nTABLE
    52. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 56\r\n \r\nTABLE 38 EUROPE INTRAOPERATIVE
    53. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      1. 57\r\n \r\nTABLE 39 EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
    54. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 58\r\n \r\nTABLE
    55. GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 59\r\n \r\nTABLE 41 GERMANY INTRAOPERATIVE
    56. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 59\r\n \r\nTABLE 42 GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL
    57. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 60\r\n \r\nTABLE
    58. GERMANY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 60\r\n \r\nTABLE 44 FRANCE INTRAOPERATIVE
    59. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 61\r\n \r\nTABLE
    60. FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 61\r\n \r\nTABLE 46 FRANCE INTRAOPERATIVE
    61. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      1. 62\r\n \r\nTABLE 47 FRANCE INTRAOPERATIVE NEUROPHYSIOLOGICAL
    62. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 62\r\n \r\nTABLE
    63. UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 63\r\n \r\nTABLE 49 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL
    64. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 63\r\n \r\nTABLE
    65. UK INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 64\r\n \r\nTABLE 51 UK INTRAOPERATIVE NEUROPHYSIOLOGICAL
    66. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 64\r\n \r\nTABLE
    67. ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 65\r\n \r\nTABLE 53 ITALY INTRAOPERATIVE
    68. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 65\r\n \r\nTABLE 54 ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL
    69. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 66\r\n \r\nTABLE
    70. ITALY INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 66\r\n \r\nTABLE 56 SPAIN INTRAOPERATIVE
    71. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 67\r\n \r\nTABLE
    72. SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 67\r\n \r\nTABLE 58 SPAIN INTRAOPERATIVE
    73. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      1. 68\r\n \r\nTABLE 59 SPAIN INTRAOPERATIVE NEUROPHYSIOLOGICAL
    74. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 68\r\n \r\nTABLE
    75. EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE,
    76. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 69\r\n \r\nTABLE 62 EASTERN EUROPE INTRAOPERATIVE
    77. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      1. 70\r\n \r\nTABLE 63 EASTERN EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL
    78. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 70\r\n \r\nTABLE
    79. ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY,
    80. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      1. MILLION) 72\r\n \r\nTABLE 66 ASIA-PACIFIC INTRAOPERATIVE
    81. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 73\r\n \r\nTABLE 67 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL
    82. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 74\r\n \r\nTABLE
    83. ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE,
    84. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      1. MILLION) 76\r\n \r\nTABLE 70 JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL
    85. MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 76\r\n \r\nTABLE
    86. JAPAN INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 77\r\n \r\nTABLE 72 JAPAN INTRAOPERATIVE
    87. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 77\r\n \r\nTABLE
    88. CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 78\r\n \r\nTABLE 74 CHINA INTRAOPERATIVE
    89. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 78\r\n \r\nTABLE 75 CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    90. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 79\r\n \r\nTABLE
    91. CHINA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 79\r\n \r\nTABLE 77 INDIA INTRAOPERATIVE
    92. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 80\r\n \r\nTABLE
    93. INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 80\r\n \r\nTABLE 79 INDIA INTRAOPERATIVE
    94. NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION)
      1. 81\r\n \r\nTABLE 80 INDIA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    95. MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 81\r\n \r\nTABLE
    96. SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023-
    97. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 82\r\n \r\nTABLE 83 SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    98. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 83\r\n \r\nTABLE
    99. SOUTH KOREA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 83\r\n \r\nTABLE 85 MIDDLE EAST & AFRICA
    100. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION, 2023–2030
      1. (USD MILLION) 84\r\n \r\nTABLE 86 MIDDLE EAST & AFRICA
    101. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD
      1. MILLION) 85\r\n \r\nTABLE 87 MIDDLE EAST & AFRICA
    102. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030
      1. (USD MILLION) 86\r\n \r\nTABLE 88 MIDDLE EAST & AFRICA
    103. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 87\r\n \r\nTABLE 89 MIDDLE EAST & AFRICA
    104. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 88\r\n \r\nTABLE 90 MIDDLE EAST INTRAOPERATIVE
    105. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030 (USD MILLION) 89\r\n \r\nTABLE
    106. MIDDLE EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE,
    107. EAST INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS, 2023–2030
      1. (USD MILLION) 90\r\n \r\nTABLE 93 MIDDLE EAST INTRAOPERATIVE
    108. NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030 (USD MILLION) 90\r\n \r\nTABLE
    109. AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE, 2023–2030
      1. (USD MILLION) 91\r\n \r\nTABLE 95 AFRICA INTRAOPERATIVE
    110. NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE, 2023–2030 (USD MILLION)
      1. 91\r\n \r\nTABLE 96 AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    111. MONITORING MARKET, BY METHODS, 2023–2030 (USD MILLION) 92\r\n \r\nTABLE
    112. AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE, 2023–2030
      1. (USD MILLION) 92\r\n \r\n11 LIST OF FIGURES\r\n \r\nFIGURE
    113. RESEARCH PROCESS 15\r\n \r\nFIGURE 2 GLOBAL INTRAOPERATIVE
    114. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 21\r\n \r\nFIGURE
    115. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 26\r\n \r\nFIGURE
    116. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 33\r\n \r\nFIGURE
    117. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 38\r\n \r\nFIGURE
    118. GLOBAL INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY REGION 42\r\n \r\nFIGURE
    119. NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
      1. 45\r\n \r\nFIGURE 8 NORTH AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL
    120. MONITORING MARKET, BY METHODS 46\r\n \r\nFIGURE 9 NORTH
    121. AMERICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 47\r\n \r\nFIGURE
    122. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY (%) 53\r\n \r\nFIGURE
    123. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 55\r\n \r\nFIGURE
    124. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE 56\r\n \r\nFIGURE
    125. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 57\r\n \r\nFIGURE
    126. EUROPE INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 58\r\n \r\nFIGURE
    127. ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY COUNTRY
      1. (%) 71\r\n \r\nFIGURE 16 ASIA-PACIFIC INTRAOPERATIVE
    128. NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 72\r\n \r\nFIGURE
    129. ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY PROCEDURE
      1. 73\r\n \r\nFIGURE 18 ASIA-PACIFIC INTRAOPERATIVE NEUROPHYSIOLOGICAL
    130. MONITORING MARKET, BY METHODS 74\r\n \r\nFIGURE 19 ASIA-PACIFIC
    131. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY SOURCE 75\r\n \r\nFIGURE
    132. MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      1. BY REGION (%) 84\r\n \r\nFIGURE 21 MIDDLE EAST &
    133. AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY TYPE 85\r\n \r\nFIGURE
    134. MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      1. BY PROCEDURE 86\r\n \r\nFIGURE 23 MIDDLE EAST & AFRICA
    135. INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET, BY METHODS 87\r\n \r\nFIGURE
    136. MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING MARKET,
      1. BY SOURCE 88

    Intraoperative Neurophysiological Monitoring Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials